This page shows the latest carflizomib news and features for those working in and with pharma, biotech and healthcare.
NICE's draft guidance is part of its assessment for NHS use of Kyprolis (carflizomib) in combination with Celgene's Revlimid (lenalidomide) and dexamethasone to treat adults who have received at
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...